Concord Biotech
Logotype for Concord Biotech Limited

Concord Biotech (CONCORDBIO) investor relations material

Concord Biotech Q3 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Concord Biotech Limited
Q3 25/26 earnings summary12 Feb, 2026

Executive summary

  • Q3 FY26 revenue grew 14% year-over-year, led by strong API segment performance and improved order execution following regulatory approvals.

  • WHO GMP certification for the injectable facility enables domestic and emerging market sales, with peak revenue potential estimated at INR 600 crore.

  • New subsidiaries established in India and the US, including Concord Lifegen and Stellon Biotech, to strengthen global expansion and commercialization.

  • Unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025, were approved without audit qualifications.

  • FY26 expected to remain below historical averages, but normalization and growth are anticipated from FY27 onward.

Financial highlights

  • Q3 FY26 revenue: INR 278 crore (14% YoY growth); nine-month revenue: INR 729 crore (5% YoY decline); consolidated Q3 revenue: INR 277.8 crore.

  • API revenue in Q3: INR 219 crore (24% YoY growth); Formulation revenue: INR 58 crore (down from INR 68 crore YoY).

  • Q3 EBITDA: INR 99 crore (margin 35.6%), impacted by startup costs; normalized margin at 40%.

  • Q3 profit after tax: INR 64 crore (Q3 FY25: INR 76 crore), affected by new labor costs and lower other income.

  • Zero debt; cash and equivalents at INR 350 crore as of December 2025.

Outlook and guidance

  • Q4 expected to be stronger, with gradual normalization of margins as injectables scale up.

  • Management expects continued demand growth, higher order inflows, and increased CDMO engagements, supported by positive trade dynamics and regulatory clarity.

  • Historical CAGR of 18% targeted, with potential to reach 25% as new growth drivers mature.

  • The company continues to monitor regulatory changes, especially regarding the new Labour Codes.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Concord Biotech earnings date

Logotype for Concord Biotech Limited
Q4 25/2615 May, 2026
Concord Biotech
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Concord Biotech earnings date

Logotype for Concord Biotech Limited
Q4 25/2615 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage